IMPORTANT MESSAGE FROM ACT EU
All clinical trials expected to continue beyond 30 January 2025 must be transitioned to the EU Clinical Trials Regulation (CTR) via the Clinical Trials Information System (CTIS). This date marks the end of a three-year transition period that began when the CTR became...
Multi-stakeholder Interview: Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Innovation and Access in Rare Cancers
The Cancer Drug Development Forum (CDDF) is delighted to share interview clips featuring a diverse group of stakeholders from our recent Multi-Stakeholder Workshop on Innovation and Access in Rare Cancers. Held in Amsterdam on 23-24 September 2024, the meeting...
Key Takeaways from the CDDF Live Webinar on EU Clinical Trial Regulations (Nov 2024)
🔔 📢 The Cancer Drug Development Forum (CDDF) held a live webinar on “EU Clinical Trial Regulations.” on 12 November at 17:00 CET. This webinar featured two lectures given by Dr Tarec Christoffer El-Galaly (Aahrus University, DK) and Stéphanie Kromar (EORTC, BE),...